(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DERMAGNOSTIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DERMAGNOSTIX

ST13

US500000088442928

Class

1, 5, 42

Filing

88442928

Registration

6098893

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

07/13/2026

Trademark type

Word

Nice classes

1, 5, 42

Filing date

05/23/2019

Registration date

07/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2020

Last transaction

07/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Freiburg, DE

Examiner

BEDNARZ, DUSTIN THOMAS

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

DERMAGNOSTIX R&D GMBH
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum fuer Gesundheit und Umwelt

Representatives

Frank S. Benjamin Dentons US LLP

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicals for use in industry and scienceIn particular oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseasesin particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and research use; Diagnostic kits for commercial and scientific purposes for detecting skin diseasespredominantly consisting of biochemical reagentsin particular containing oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseasesin particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and research use; Diagnostic agents other than for medical and veterinary purposes

Class 5

PharmaceuticalsIn particular products for treating skin diseasesin particular for treating psoriasis and atopic eczema; Diagnostic preparations for medical purposesin particular in the field of dermatologyin particular in the field of diagnosing skin diseasesin particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseasesin particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemain particular containing oligonucleotides and antibodies

Class 42

Scientific and industrial research in particular in the biochemicaldiagnostic and pharmaceutical fields; Laboratory research services relating to pharmaceuticalsin particular in the field of dermatologyin particular in the field of diagnosing skin diseasesin particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseasesin particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and industrial research purposes

Publications

History of USPTO decisions and trademark events.

41 publications found

E815

TEAS SECTION 8 & 15 RECEIVED

07/13/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/25/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/25/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/25/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/05/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/05/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/05/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/05/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/05/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/03/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/28/2020

PUBO

PUBLISHED FOR OPPOSITION

04/28/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/08/2020

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

03/23/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

03/20/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/19/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/18/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/17/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/16/2020

GNSL

LETTER OF SUSPENSION E-MAILED

03/16/2020

CNSL

SUSPENSION LETTER WRITTEN

03/16/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/05/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/20/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/20/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/20/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/20/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/20/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/20/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/20/2019

GNRT

NON-FINAL ACTION E-MAILED

08/20/2019

CNRT

NON-FINAL ACTION WRITTEN

08/20/2019

DOCK

ASSIGNED TO EXAMINER

08/13/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/07/2019

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

06/07/2019

ALIE

ASSIGNED TO LIE

06/03/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

05/29/2019

NWAP

NEW APPLICATION ENTERED

05/27/2019

Continuous trademark protection

Get notified about every new filing that threatens DERMAGNOSTIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.